Ads
related to: arwr stock
Search results
Arrowhead CEO Christopher Anzalone Addresses This 'Really Important Event' In Lung Disease
Investor's Business Daily· 12 months agoArrowhead Pharmaceuticals said Thursday a single dose of its experimental drug almost completely...
Arrowhead Pharmaceuticals Surges After Hinting At A Midstage Win In Liver Disease
Investor's Business Daily· 1 year agoArrowhead Pharmaceuticals has provided a bullish update for its midstage liver disease treatment,...
Is Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Expensive For A Reason? A Look At Its Intrinsic...
Simply Wall St. via Yahoo Finance· 3 months agoKey Insights Using the 2 Stage Free Cash Flow to Equity, Arrowhead Pharmaceuticals fair value...
Is Arrowhead Pharmaceuticals (ARWR) Too Good to Be True? A Comprehensive Analysis of a ...
GuruFocus.com via Yahoo Finance· 9 months agoFor value-focused investors, the quest for stocks trading below their intrinsic value is relentless....
Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) recent 4.3% pullback adds to one-year year losses,...
Simply Wall St. via Yahoo Finance· 2 years agoEvery investor in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) should be aware of the most powerful...
Investing in Arrowhead Pharmaceuticals (NASDAQ:ARWR) five years ago would have delivered you a 329%...
Simply Wall St. via Yahoo Finance· 1 year agoArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) shareholders might be concerned after seeing the share...
Institutional investors may adopt severe steps after Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR)...
Simply Wall St. via Yahoo Finance· 1 month agoKey Insights Significantly high institutional ownership implies Arrowhead Pharmaceuticals' stock...
Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) Shares Climb 25% But Its Business Is Yet to Catch Up
Simply Wall St. via Yahoo Finance· 1 year agoThose holding Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) shares would be relieved that the share...
Great week for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) institutional investors after losing...
Simply Wall St. via Yahoo Finance· 7 months agoKey Insights Institutions' substantial holdings in Arrowhead Pharmaceuticals implies that they have...
Swelling losses haven't held back gains for Arrowhead Pharmaceuticals (NASDAQ:ARWR) shareholders...
Simply Wall St. via Yahoo Finance· 9 months agoIt hasn't been the best quarter for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) shareholders,...
